Recently, miR-26b-5p has been shown to target the MAPK and AKT/mTOR signaling pathways by binding to the 3′ UTR of TRAF5 or TRIM44, respectively [120,121], which are involved in the malignant progression of melanoma cells. The gene discussed is AKT1; the disease is melanoma.